Skip to main content

Table 1 Patient and disease characteristics

From: Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs

Characteristic

Study 1 (n = 339)

Study 2 (n = 346)

Study 3 (n = 548)

Study 4 (n = 394)

Total (N = 1627)

Age (mean ± SD)

36.21 ± 10.73

41.05 ± 9.58

39.10 ± 11.8

41.59 ± 9.74

39.53 ± 10.85

Sex (Male %)

220(64.9)

228(65.9)

352(64.2)

248(62.9)

1048(64.4)

Race (Caucasian %)

253(74.6)

179(51.7)

239(43.6)

197(50.0)

868(53.3)

Diagnosis (%)

     

   Schizophrenia

277(81.7)

230(66.5)

548(100)

223(56.6)

1278(78.5)

   Schizoaffective

52(15.3)

116(33.5)

--

171(43.4)

339(20.84)

   Schizophreniform

10(2.9)

--

--

--

10(0.6)

Age of Onset Illness (yrs ± SD)

23.51 ± 7.48

23.36 ± 8.21

23.37 ± 8.27

23.71 ± 8.93

23.48 ± 8.26

PANSS Total (mean ± SD)

96.08 ± 16.55

84.83 ± 14.03

100.9 ± 20.18

79.35 ± 17.51

91.27 ± 19.72

Prior Hospitalization (%)

337(99.4)

180(52.0)

105(19.2)

189(48.0)

811(49.8)

Hospitalization Days (mean ± SD)*

23.12 ± 43.89

55.45 ± 77.13

16.10 ± 37.4

41.12 ± 44.10

33.58 ± 54.31

Illness Duration (yrs ± SD)

12.57 ± 9.75

17.68 ± 9.50

15.80 ± 11.63

17.84 ± 10.59

16.02 ± 10.75

  1. * Mean hospitalization days for group of patients reporting prior hospitalization.